Coding and non-coding variants in the ciliopathy gene CFAP410 cause early-onset non-syndromic retinal degeneration
Riccardo Sangermano(Radboud University Nijmegen), Kinga M. Bujakowska(Massachusetts Eye and Ear Infirmary), Isabelle Audo(Inserm), Xavier Zanlonghi(Centre Hospitalier Universitaire de Rennes), Rachel M. Huckfeldt(Penn Presbyterian Medical Center), José-Alain Sahel(Centre National de la Recherche Scientifique), Eric A. Pierce(Broad Institute), Shizuo Mukai(Massachusetts Eye and Ear Infirmary), Priya Gupta(Sharda University), Christina Zeitz(Centre National de la Recherche Scientifique), Jinu Han(Severance Hospital), Christel Condroyer(University of Namur), Jacque L. Duncan, Emily Place(MACOM (United States)), Emily O’Heir(MACOM (United States)), C W Price(Massachusetts Eye and Ear Infirmary), Aline Antonio(Centre National de la Recherche Scientifique), Julien Navarro(Centre National de la Recherche Scientifique), Stephanie DiTroia(Broad Institute)
Cited by 2
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
|Proceedings of the National Academy of Sciences|1995|1k